Manning & Napier Advisors Inc. was founded in April 1970 by Bill Manning and Bill Napier and for more than four decades, it has been guiding individual and institutional clients toward their financial goals.
The following are its most heavily weighted buys during the first quarter:
The guru acquired 5,395,810 shares in ServiceNow Inc. (NOW) with an impact of 2.09% on the portfolio.
The company along with its subsidiaries is a provider of cloud-based services to automate enterprise IT operations. The services include a suite of applications built on a proprietary platform that automates workflow and integrates related business processes. During the fourth quarter total revenues had an increase of 44% year over year and 51% in constant currency. Free cash flow had an increase of 107% year over year.
GuruFocus gives the stock a profitability and growth rating of 4 out of 10 with ROE of -40.82% and ROA of -12.48% that are underperforming 86% of the companies in the Global Information Technology Services industry. Financial strength has a rating of 7 out of 10 with cash to debt of 1.69 that is far below the industry median of 12.17.
Other notable shareholders among the gurus are Steven Cohen (Trades, Portfolio) with 0.06% of outstanding shares followed by Pioneer Investments (Trades, Portfolio) with 0.05%, Ron Baron (Trades, Portfolio) with 0.05%, John Burbank (Trades, Portfolio) with 0.03%, Ken Fisher (Trades, Portfolio) with 0.01% and Paul Tudor Jones (Trades, Portfolio) with 0.01%.
The fund raised its stake in Medtronic PLCĂ‚ (MDT) by 55.42% with an impact of 1.32% on the portfolio.
The company is a medical technology company – alleviating pain, restoring health and extending life for millions of people around the world. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders and ear, nose and throat and diabetes conditions. Fourth-quarter revenue increased 60% when compared to the $4.57 billion reported by Medtronic Inc. in the fourth quarter of fiscal year 2014.
GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 5.31% and ROA of 2.57% that are outperforming 57% of the companies in the Global Medical Devices industry. Financial strength has a rating of 7 out of 10 with cash to debt of 0.48 that is below the industry median of 2.49.
Barrow, Hanley, Mewhinney & Strauss is the company's largest shareholder among the gurus with 1.68% of outstanding shares followed by Vanguard Health Care Fund (Trades, Portfolio) with 1.11%, PRIMECAP Management (Trades, Portfolio) with 0.84%, Manning & Napier Advisors with 0.43%, Dodge & Cox with 0.38%, Jeremy Grantham (Trades, Portfolio) with 0.25% and Pioneer Investments (Trades, Portfolio) with 0.24%.
The guru increased its stake in BlackRock Inc. (BLK) by 526.54% with an impact of 1.18% on the portfolio.
It is a publicly traded investment management firm with employees in more than 30 countries who serve clients in more than 100 countries. It provides a range of investment and risk management services.
GuruFocus gives the stock a profitability and growth rating of 8 out of 10 with ROE of 12.02% that is outperforming and ROA of 1.43% that is underperforming other companies in the Global Asset Management industry. Financial strength has a rating of 5 out of 10 with cash to debt of 1.26.
Other notable shareholders among the gurus are Tom Gayner (Trades, Portfolio) with 0.09% of outstanding shares followed by Fisher with 0.05%, Ken Heebner (Trades, Portfolio) with 0.03% and Joel Greenblatt (Trades, Portfolio) with 0.03%.
The fund raised its stake in Facebook Inc. (FB) by 109.94% with an impact of 0.94% on the portfolio.
The company is a social networking website that builds products that create utility for users, developers and advertisers. During the last quarter revenue had an increase of 44% year over year and Mobile MAUs had an increase of 21% year over year.
GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 9.23% and ROA of 8.31% that are outperforming 57% of the companies in the Global Internet Content & Information industry. Financial strength has a rating of 9 out of 10 with cash to debt of 58.52 that is above the industry median of 22.40.
Frank Sands (Trades, Portfolio) is the company's largest shareholder among the gurus with 0.84% of outstanding shares followed by Steve Mandel (Trades, Portfolio) with 0.34%, John Griffin (Trades, Portfolio) with 0.11%, Chris Davis (Trades, Portfolio) with 0.09% and Stanley Druckenmiller (Trades, Portfolio) with 0.09%.
The guru increased its stake in Qualcomm Inc. (QCOM) by 40.93% \with an impact of 0.88% on the portfolio.
The company develops and commercializes digital communication technology called CDMA (Code Division Multiple Access) and owns intellectual property applicable to products that implement any version of CDMA including patents, patent applications and trade secrets.
GuruFocus gives the stock a profitability and growth rating of 8 out of 10 with ROE of 13.98% and ROA of 9.63% that are outperforming 80% of the companies in the Global Communication Equipment industry. Financial strength has a rating of 8 out of 10 with cash to debt of 1.51 that is below the industry median of 2.45.
The company's largest shareholder among the gurus is Barrow, Hanley, Mewhinney & Strauss with 1.22% of outstanding shares followed by PRIMECAP Management (Trades, Portfolio) with 1.08%, Fisher with 0.63%, Jana Partners (Trades, Portfolio) with 0.62%, Grantham with 0.6%, David Rolfe (Trades, Portfolio) with 0.56% and T Rowe Price Equity Income Fund (Trades, Portfolio) with 0.35%.
The guru raised its stake in Cerner Corp. (CERN) by 45.90% with an impact of 0.73% on the portfolio.
The company is a supplier of health care information technology and offers solutions and services that support the clinical, financial and operational needs of organizations. Bookings in the fourth quarter of 2015 grew 16% compared to the fourth quarter 2014 and revenue increased 27%.
GuruFocus gives the stock a profitability and growth rating of 8 out of 10 with ROE of 14.41% and ROA of 10.19% that are outperforming 73% of the companies in the Global Health Information Services industry. Financial strength has a rating of 7 out of 10 with cash to debt of 0.85 that is below the industry median of 12.17.
Vanguard Health Care Fund (Trades, Portfolio) is the company's largest shareholder among the gurus with 4.83% of outstanding shares followed by Sands with 3.97%, Meridian Funds (Trades, Portfolio) with 0.29%, Baron with 0.07% and Louis Moore Bacon (Trades, Portfolio) with 0.05%.
The guru bought 877,770 shares in Perrigo Co PLCĂ‚ (PRGO) with an impact of 0.73% on the portfolio.
The company develops, manufactures and distributes over-the-counter and generic prescription pharmaceuticals, nutritional products and active pharmaceutical ingredients.
GuruFocus gives the stock a profitability and growth rating of 6 out of 10 with ROE of -0.32% and ROA of -0.18% that are underperforming 67% of the companies in the Global Drug Manufacturers - Specialty & Generic industry. Financial strength has a rating of 5 out of 10, with cash to debt of 0.07 that is far below the industry median of 3.29.
The largest shareholder among the gurus is John Rogers (Trades, Portfolio) with 1.86% of outstanding shares followed by Rolfe with 1.48%, Ruane Cunniff (Trades, Portfolio) with 1.01%, Manning & Napier Advisors with 0.61%, Eric Mindich (Trades, Portfolio) with 0.59%, Meridian Funds (Trades, Portfolio) with 0.34% and Baron  with 0.18%.
